Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension.
about
Prevention of Hepatocellular CarcinomaAPASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis.Long-term outcome of chronic hepatitis C virus infection in a real-world setting: The German LOTOS study.Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.Impact of etiological treatment on prognosis.Viral hepatitis and liver cancer.Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort.The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience."Hep C, where art thou": What are the remaining (fundable) questions in hepatitis C virus research?HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.Impact of hepatitis C oral therapy in portal hypertension.Hepatitis C Virus Clearance in Older Adults.Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.Hepatocellular carcinoma and direct-acting antivirals: A never ending story?Regression of HCV cirrhosis: Time will tell.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.Management of Patients Who Have Achieved Sustained Virologic Response for Hepatitis C Virus Infection.Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needsThe impact of antiviral therapy on hepatocellular carcinoma epidemiologyImpact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues
P2860
Q28079576-C9D7F01E-7E09-4734-AC5A-D504EEFE7181Q30250088-A9302B52-A03A-4D69-B264-0F361B6FB1BCQ36334385-CD1C04BE-CFE7-4409-93BD-E1AFDC2A6E38Q38936212-5AA5CA49-A6B4-4856-9A2A-97E8F5736F2EQ39240225-91F49673-9AE3-4521-B7C3-4DB4B6193E9CQ39431994-0CBE68E7-61FD-4E78-BDF9-F4ED06F64B74Q40046596-9AB5FBB4-A7A8-425C-B565-64FF980C23A2Q40121053-BA4145FA-4705-4CB9-947A-9EE63F76DFDEQ40201286-9740D689-E2EE-4DAC-8381-9B139A585CEBQ40536482-7952E1B9-C8A1-42EB-B3E6-477B745B5B41Q40612995-65D66652-90DD-4FFA-A331-559D1DA9553FQ40680346-E8AA1996-D6B4-493A-97F5-E00AE2DACD4AQ41924669-A3DBB885-4CB5-405D-9C9B-15544CF282FDQ42334110-02A906A8-6160-4433-92B9-2FB47F1A171EQ45324869-4DB96CFD-7F80-450B-AF20-CDB4C38EC5E9Q47109230-75FA8545-2340-4C6A-8E3F-01412BD88219Q48092639-980D3F5B-FCD8-42E5-950A-0045B203A55BQ49984573-D02EC7BB-0C6C-453F-B230-B295DDC80BEEQ50350640-A77AD8F6-96DC-4419-AE77-FB829D9577E6Q55348708-7E788FB5-B568-420A-8FB0-B7C69138289DQ55477214-2D37BF42-66E5-4B96-93C6-6D258521B62EQ57020823-A27C04EF-1159-464B-9FF3-109B118DA9E3Q57301376-87141EA5-5D6D-41BC-8E64-4A8194428381Q58541835-BA9FFEDF-EABA-4713-9F71-459A8C25BF09
P2860
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Effects of Eradicating Hepatit ...... Stage of Portal Hypertension.
@en
type
label
Effects of Eradicating Hepatit ...... Stage of Portal Hypertension.
@en
prefLabel
Effects of Eradicating Hepatit ...... Stage of Portal Hypertension.
@en
P2093
P921
P1433
P1476
Effects of Eradicating Hepatit ...... Stage of Portal Hypertension.
@en
P2093
Andrea Arini
Antonio Craxì
Calogero Cammà
Donatella Ferraro
Elisabetta Conte
Fabio Simone
Maria Grazia Bavetta
Rosaria Maria Pipitone
Sergio Peralta
Stefania Grimaudo
P304
130-139.e2
P356
10.1053/J.GASTRO.2016.03.036
P407
P577
2016-03-31T00:00:00Z